MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans - Esposito, I; Cicconi, P; D'Alise, AM; Brown, A; Esposito, M; Swadling, L; Holst, PJ; Bassi, MR; Stornaiuolo, M; Mori, F; Vassilev, V; Li, W; et al. (Science Translational Medicine, 2020)